TABLE OF CONTENTS
1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF THE NORTH AMERICA N95 MASK MARKET 40
1.4 LIMITATION 42
1.5 MARKETS COVERED 42
2 MARKET SEGMENTATION 46
2.1 MARKETS COVERED 46
2.2 GEOGRAPHICAL SCOPE 47
2.3 YEARS CONSIDERED FOR THE STUDY 48
2.4 CURRENCY AND PRICING 48
2.5 DBMR TRIPOD DATA VALIDATION MODEL 49
2.6 MULTIVARIATE MODELLING 52
2.7 PRODUCT SEGMENT LIFELINE CURVE 52
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53
2.9 DBMR MARKET POSITION GRID 54
2.10 MARKET APPLICATION COVERAGE GRID 55
2.11 VENDOR SHARE ANALYSIS 56
2.12 SECONDARY SOURCES 57
2.13 ASSUMPTIONS 57
3 EXECUTIVE SUMMARY 58
3.1 PESTEL ANALYSIS 62
3.2 PORTER'S FIVE FORCES MODEL 63
4 INDUSTRY INSIGHTS 64
5 NORTH AMERICA N95 MASK MARKET: REGULATORY FRAMEWORK 66
6 MARKET OVERVIEW 69
6.1 DRIVERS 71
6.1.1 INCREASE IN AIR POLLUTION LEVELS 71
6.1.2 RISING PREVALENCE OF RESPIRATORY DISEASES 72
6.1.3 MANDATORY OCCUPATIONAL SAFETY REGULATIONS FOR WORKERS IN VARIOUS INDUSTRY 72
6.1.4 INCREASED AWARENESS ABOUT THE SIGNIFICANT BENEFITS OF THE N95 MASK 74
6.2 RESTRAINTS 75
6.2.1 ENVIRONMENTAL CONCERNS ASSOCIATED WITH THE DISPOSAL OF N95 MASKS 75
6.2.2 INCREASED USE OF HOMEMADE MASK 76
6.3 OPPORTUNITIES 76
6.3.1 TECHNOLOGICAL ADVANCEMENT PROMOTING THE MANUFACTURING OF ECO-FRIENDLY N95 MASKS 76
6.3.2 RISING HEALTH AND SAFETY CONCERNS AGAINST INFECTIOUS DISEASES AMONG THE CONSUMERS 77
6.3.3 SIGNIFICANT RISE IN THE USE OF N95 MASKS IN THE HEALTHCARE INDUSTRY 78
6.4 CHALLENGES 79
6.4.1 LIMITED PRODUCTION CAPACITY AND MACHINERY FOR MEETING THE DESIRED QUALITY OF N95 MASKS 79
6.4.2 PHYSIOLOGICAL EFFECTS ASSOCIATED WITH THE PROLONGED USE OF N95 MASKS 80
7 NORTH AMERICA N95 MASK MARKET, BY PRODUCT 81
7.1 OVERVIEW 82
7.2 STANDARD N95 MASKS 85
7.2.1 BY VALVES 86
7.2.1.1 WITHOUT VALVE 86
7.2.1.2 WITH VALVE 86
7.2.2 BY STYLE 86
7.2.2.1 MOLDED CUP 86
7.2.2.2 FLAT FOLD 86
7.3 SURGICAL N95 MASKS 87
7.3.1 BY VALVES 87
7.3.1.1 WITHOUT VALVE 88
7.3.1.2 WITH VALVE 88
7.3.2 BY STYLE 88
7.3.2.1 MOLDED CUP 88
7.3.2.2 FLAT FOLD 88
8 NORTH AMERICA N95 MASK MARKET, BY APPLICATION 89
8.1 OVERVIEW 90
8.2 INFECTIOUS DISEASES 93
8.2.1 VIRUSES 94
8.2.2 BACTERIA 94
8.2.3 FUNGI 94
8.2.4 PARASITES 94
8.2.5 OTHERS 94
8.3 RESPIRATORY SAFETY 94
8.3.1 DUSTS 95
8.3.2 FUMES 95
8.3.3 MISTS 96
8.3.4 FOG 96
8.3.5 SPRAYS 96
8.3.6 SMOKES 96
8.3.7 GASES 96
8.3.8 VAPORS 96
8.3.9 OTHERS 96
8.4 ALLERGIES 96
8.4.1 POLLENS 97
8.4.2 DUST MITES 97
8.4.3 PARTICULATES 97
8.4.4 PET ALLERGENS 97
8.4.5 OTHERS 98
8.5 SURGERIES 98
9 NORTH AMERICA N95 MASK MARKET, BY TYPE OF MATERIAL 99
9.1 OVERVIEW 100
9.2 POLYPROPYLENE (PP) 103
9.3 POLYURETHANE 103
9.4 POLYESTER 104
9.5 COTTON 105
10 NORTH AMERICA N95 MASK MARKET, BY USABILITY 106
10.1 OVERVIEW 107
10.2 DISPOSABLE 110
10.3 REUSABLE 111
11 NORTH AMERICA N95 MASK MARKET, BY SIZE 112
11.1 OVERVIEW 113
11.2 STANDARD SIZE 116
11.3 SMALL SIZE 116
11.4 OTHERS 117
12 NORTH AMERICA N95 MASK MARKET, BY END USER 118
12.1 OVERVIEW 119
12.2 HOSPITALS 122
12.2.1 LONG-TERM CARE HOSPITALS 123
12.2.2 ACUTE CARE HOSPITALS 123
12.2.3 NURSING FACILITIES 123
12.2.4 REHABILITATION CENTERS 123
12.3 CLINICS 123
12.4 AMBULATORY SURGICAL CENTERS 124
12.5 DIAGNOSTIC LABORATORIES 124
12.6 PUBLIC SAFETY SERVICE ORGANIZATION 125
12.7 CONSTRUCTION COMPANIES 126
12.8 MANUFACTURING COMPANIES 127
12.9 OIL & GAS COMPANIES 128
12.10 INDIVIDUAL 128
12.11 OTHERS 129
13 NORTH AMERICA N95 MASK MARKET, BY DISTRIBUTION CHANNEL 130
13.1 OVERVIEW 131
13.2 ONLINE SALES 134
13.2.1 ONLINE PHARMACIES 135
13.2.2 OTHERS 135
13.3 OFFLINE SALES 135
13.3.1 HOSPITAL PHARMACIES 136
13.3.2 SUPERMARKET/HYPERMARKET 136
13.3.3 DRUG STORE 136
13.3.4 RETAIL PHARMACIES 136
14 NORTH AMERICA N95 MASK MARKET, BY REGION 137
14.1 NORTH AMERICA 138
14.1.1 U.S. 148
14.1.2 CANADA 153
14.1.3 MEXICO 158
15 NORTH AMERICA N95 MASK MARKET, COMPANY LANDSCAPE 163
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 163
16 SWOT ANALYSIS 164
17 COMPANY PROFILE 165
17.1 3M 165
17.1.1 COMPANY SNAPSHOT 165
17.1.2 REVENUE ANALYSIS 165
17.1.3 COMPANY SHARE ANALYSIS 166
17.1.4 PRODUCT PORTFOLIO 166
17.1.5 RECENT DEVELOPMENT 166
17.2 HONEYWELL INTERNATIONAL INC. 167
17.2.1 COMPANY SNAPSHOT 167
17.2.2 REVENUE ANALYSIS 167
17.2.3 COMPANY SHARE ANALYSIS 168
17.2.4 PRODUCT PORTFOLIO 168
17.2.5 RECENT DEVELOPMENT 168
17.3 KIMBERLY-CLARK 169
17.3.1 COMPANY SNAPSHOT 169
17.3.2 REVENUE ANALYSIS 169
17.3.3 COMPANY SHARE ANALYSIS 170
17.3.4 PRODUCT PORTFOLIO 170
17.3.5 RECENT DEVELOPMENT 170
17.4 CARDINAL HEALTH 171
17.4.1 COMPANY SNAPSHOT 171
17.4.2 REVENUE ANALYSIS 171
17.4.3 COMPANY SHARE ANALYSIS 172
17.4.4 PRODUCT PORTFOLIO 172
17.4.5 RECENT DEVELOPMENT 172
17.5 OWENS & MINOR 173
17.5.1 COMPANY SNAPSHOT 173
17.5.2 REVENUE ANALYSIS 173
17.5.3 COMPANY SHARE ANALYSIS 174
17.5.4 PRODUCT PORTFOLIO 174
17.5.5 RECENT DEVELOPMENT 174
17.6 ALPHAPROTECH 175
17.6.1 COMPANY SNAPSHOT 175
17.6.2 REVENUE ANALYSIS 175
17.6.3 PRODUCT PORTFOLIO 176
17.6.4 RECENT DEVELOPMENT 176
17.7 MAKRITE 177
17.7.1 COMPANY SNAPSHOT 177
17.7.2 PRODUCT PORTFOLIO 177
17.7.3 RECENT DEVELOPMENT 177
17.8 MEDLINE INDUSTRIES, LP 178
17.8.1 COMPANY SNAPSHOT 178
17.8.2 PRODUCT PORTFOLIO 178
17.8.3 RECENT DEVELOPMENT 178
17.9 MOLDEX-METRIC 179
17.9.1 COMPANY SNAPSHOT 179
17.9.2 PRODUCT PORTFOLIO 179
17.9.3 RECENT DEVELOPMENT 180
17.10 PRESTIGE AMRITECH 181
17.10.1 COMPANY SNAPSHOT 181
17.10.2 PRODUCT PORTFOLIO 181
17.10.3 RECENT DEVELOPMENT 181
17.11 THE GERSON COMPANY 182
17.11.1 COMPANY SNAPSHOT 182
17.11.2 PRODUCT PORTFOLIO 182
17.11.3 RECENT DEVELOPMENT 182
18 QUESTIONNAIRE 183
19 RELATED REPORTS 187

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.